This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: Sumie Muramatsu: Innovator in Autoimmune Disease Treatment
Introduction
Sumie Muramatsu is a prominent inventor based in Sumida-ku, Japan. She has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With a total of 2 patents, her work focuses on innovative methods that leverage monoclonal antibodies to combat these challenging conditions.
Latest Patents
Muramatsu's latest patents include groundbreaking methods for treating autoimmune diseases that incorporate an anti-LAG3 antibody. These methods involve administering a monoclonal antibody or a binding fragment that targets domain 3 of human LAG-3. The properties of this antibody include in vitro ADCC activity, the ability to reduce the number of LAG-3 positive cells in vivo in low fucose form, and the suppression of experimental autoimmune encephalomyelitis. Additionally, the antibody binds to human activated T cells and allows human LAG-3 to exert a T cell suppression function.
Another notable patent is for a novel antibody designed for treating autoimmune diseases. This invention also focuses on a monoclonal antibody or a binding fragment that binds to domain 3 of human LAG-3, sharing similar properties to her previous patent. These advancements represent a significant step forward in the treatment of autoimmune disorders.
Career Highlights
Sumie Muramatsu is currently associated with Daiichi Sankyo Company, Limited, where she continues her research and development efforts. Her work has garnered attention in the scientific community, contributing to advancements in therapeutic strategies for autoimmune diseases.
Collaborations
Muramatsu collaborates with esteemed colleagues, including Ryuta Mukasa and Kensuke Nakamura. Their combined expertise enhances the research and development of innovative treatments in the field.
Conclusion
Sumie Muramatsu's contributions to the field of autoimmune disease treatment through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for new therapeutic options that can significantly improve patient outcomes.